Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Language
Year range
1.
Chinese Pharmaceutical Journal ; (24): 1508-1510, 2019.
Article in Chinese | WPRIM | ID: wpr-857911

ABSTRACT

OBJECTIVE: To research and compare the antimicrobial effects of propofol fat emulsion injection (PFEI) which contains disodium edetate (EDTA) or not. METHODS: According to the requirements of Antimicrobial Effectiveness in 2015 edition of Chinese Pharmacopoeia (Ch. P volume 4, 1121), Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Aspergillus niger and Candida albicans were used as the test microorganisms, the number of viable microorganisms in 3 batches of PFEI with and without EDTA was determined at 12 h after inoculation. RESULTS: Compared with zero hour, the number of viable microorganisms in PFEI which contains EDTA didn't increase at 12 h, therein the number of Pseudomonas aeruginosa, Escherichia coli and Candida albicans increased by about 0.5 lg; however, the number of Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Candida albicans in the samples without EDTA increased by 0.5, 0.4, 0.6 and 1.6 lg respectively, except for Aspergillus niger which did not increase. CONCLUSION: Compared with PFEI without EDTA, the samples containing EDTA may reduce the risk of infection caused by accidental contamination. However, it cannot reduce all pathogenic threats for propofol preparations.

2.
Chinese Journal of Clinical Nutrition ; (6): 354-360, 2018.
Article in Chinese | WPRIM | ID: wpr-744603

ABSTRACT

Objective To systemically analyze the efficacy and safety of multi-oil fat emulsion injection (SMOF) in the premature infant parenteral nutrition support.Methods Databases including EMbase,PubMed,Cochrane Library,CNKI,VIP and Wanfang,were searched from libraries establishment to November 2017 for randomized controlled trials (RCTs) focusing on the efficacy and safety of SMOF in the premature infant parenteral nutrition support.All the literatures were retrieved and screened according to inclusion and exclusion criteria by two researchers.The software RevMan 5.3 was used for meta-analysis after the evaluation of methodology of quality.Results A total of 7 articles including 7 RCTs were enrolled.Meta-analysis showed that there were no significant differences in body length (OR=-0.25,95% CI=-1.80-1.30,P=0.75),weight (OR=-0.12,95% CI=-0.20-0.04,P=0.14),head circumference (OR=0.07,95% CI=-0.83-0.96,P=0.88),lowdensity lipoprotein,high-density lipoprotein,direct bilirubin,serum creatinine (OR=-0.16,95% CI=-0.59-0.26,P=0.45) between the infants receiving SMOF or Intralipid.But compared with the infants receiving Intralipid,hemoglobin (OR=-0.75,95% CI=-1.49-0.00,P=0.05),red blood cells (OR=-0.23,95% CI=-0.45-0.00,P=0.05) decreased in the infants receiving SMOF,and white blood cells (OR=1.91,95% CI=0.46-3.37,P =0.01) increased.Conclusions SMOF can control the hemoglobin content in serum,reduce the risk and degree of jaundice in premature infant,with better safety.

3.
Chinese Journal of Biochemical Pharmaceutics ; (6): 21-23, 2017.
Article in Chinese | WPRIM | ID: wpr-613953

ABSTRACT

Objective A high performance liquid chromatographic (HPLC) method was established for the determination of glycerol in propofol medium and long chain fat emulsion injection.MethodsThe chromatographic conditions were as follows: Kromasil 100-5-NH2 column(4.6×250mm,5μm) with the column temperature was 40℃,acetonitrile-water(8515)as mobile phase with flow rate of 1.0mL/min.Glycerol was detected by refractive index (RI) detector at 40℃.ResultsThe linear range of glycerol was 455.3916-2276.9580μg/mL(r=0.9999,n=7),the average recovery rate was 99.5%,RSD was 0.6%(n=9),the limit of detection(LOD) was 121ng and the limit of quantification(LOQ)was 364ng.ConclusionThe method was simple, rapid, strong specifity and accurate with good reproducibility, which is suitable for the content determination of glycerol in propofol medium and long chain fat emulsion injection.

4.
Drug Evaluation Research ; (6): 1642-1644, 2017.
Article in Chinese | WPRIM | ID: wpr-664522

ABSTRACT

Objective To evaluate the clinical application of Fat Emulsion Injection in tumor patients and provide references for rational drug use.Methods A total of 1500 cases administered with Fat Emulsion Injection during January and December 2016 in Affiliated Cancer Hospital of Zhengzhou University were collected randomly and evaluated with the relevant standards.Results From the investigation of a total of 1 500 patients with cancer,fat Emulsion Injection was mainly used in the surgery department (68.2%).Of 1500 cases,unreasonable medical records accounted for 35.2 %;inappropriate indication accounted for 16.1%,inappropriate selection of drugs accounted for 44.5%,incorrect dosage accounted for 50.6%,and incompatibility accounted for 18.3%.Conclusion Unreasonable use of Fat Emulsion Injection in the hospital is prevalent,therefore,measures should be taken to strengthen the standard use of this kind of drugs.

5.
Chinese Journal of Clinical Nutrition ; (6): 359-363, 2009.
Article in Chinese | WPRIM | ID: wpr-391680

ABSTRACT

Objective To compale the physical and chemical parameters of three market available medi-an/long chain fat emulsions.Methods The quality properties were determined and compared according to the fat emulsion injection quality standards in the Chinese Pharmacopeia Convention,the United States Pharmacopeia Con-vention,and the National Standard.Results Products A:the pH value was between 8.2-8.3;the particles with a size larger than 1 μm were 1.23%-1.53% and no particles were larger than 5 μm;the mean particle size was 0.246-0.256μm;the acid value was 0.2;the peroxide and methoxyl aniline values were 0 and 0.9-1.4;the he-molysis phosphatide was 0.6-0.9 g/L. The contents of fat,glycerin,and triglycerides were more than 97% of the labeled amounts;the content of phosphorus was 0.46-0.49 g/L. Products B:the pH value was between 8.2;the partocles with a size larger than 1 μm were 0.81%-1.62% and no particles were larger than 5 μm;the mean parti-cle size was 0.239-0.241 μm;the acid value was 0.4-0.5;the peroxide and methoxyl aniline values were 0 and 0.8-1.4;the hemolysis phosphatide was 0.2-0.6 g/L. The contents of fat,glycerin,and triglycerides were more than 94% of the labeled amounts;the content of phosphorus was 0.42 g/L. Products C:the pH value was between 7.7-8.1;the particles with a size larger than 1 μm were 0.42%-0.86% and no particles were larger than 5 μm;the mean particle size was 0.249-0.262 μm;the acid value was 0.3-0.4;the peroxide and methoxyl aniline values were 0 and 1.8-2.9;the hemolysis phosphatide was 0.5-0.8 g/L. The contents of fat,glycerin,and triglycerides were mole than 96% of the labeled amounts;the content of phosphoms was 0.44-0.46 g/L. Conclusion All properties of the median/long chain fat emulsions produced by the three manufacturers met the National Standard.

6.
China Pharmacy ; (12)2007.
Article in Chinese | WPRIM | ID: wpr-534513

ABSTRACT

OBJECTIVE: To explore the regularity and characteristics of ADR cases induced by Fat emulsion injection, and to provide reference for rational use of it. METHODS: Retrieved from Chinese medical science periodicals from Jan. 1990 to Apr. 2010, 97 ADR cases induced by Fat emulsion injection were analyzed statistically. RESULTS: Main clinical manifestations of ADR cases induced by Fat emulsion injection were allergy reaction, followed by fat overloading syndrome, central nervous system reaction. The majority of ADR cases broke out in the first time of medication within 2 hour. CONCLUSION: It is essential for clinical practitioners to master the characteristics of ADR cases caused by Fat emulsion injection so as to promote safety of drug use.

SELECTION OF CITATIONS
SEARCH DETAIL